Archive

Covid and lapses create pricing uncertainty in life ILS markets

Market participants optimistic about opportunities despite investor hesitancy

Securis launches fourth life ILS fund

The alternative in life

Luca Tres has been a pioneer in the development of the life ILS markets. As he begins a new role at Guy Carpenter, he talks to Christopher Cundy about the past and future at the intersection of re/insurance and capital markets

Genetic testing risks go under the microscope

Do life insurers really face the risk of adverse selection from customers that have taken predictive genetic tests? Academics think not, and insurers and policyholders could indeed benefit from wider use of genetic testing, as Paul Walsh reports

IFRS 17 earnings recognition: challenges, opportunities and innovations

Luca Tres and Adam Robinson discuss IFRS 17 and its earning recognition criteria from a capital markets and insurance practitioner's perspective, and consider the challenges and the opportunities this presents

Finalists announced for InsuranceERM Awards

See which companies, teams and individuals have made the shortlist for this year's awards for risk and capital management

Lapse risk takes centre stage in capital management strategies

Since the introduction of Solvency II, EU life insurers have had to hold much more capital against the risk of customers lapsing their policies. Luca Tres explains how innovative hedging structures can help firms maximise their capital efficiency